作者: Hiromi I. Wettersten , Robert H. Weiss
关键词:
摘要: In this Review, Wettersten and Weiss discuss novel urinary blood biomarkers therapeutic targets for renal cell carcinoma, with the hope that dissemination of information might lead to clinical utilization.